img

Global Anti-Ageing Drugs Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anti-Ageing Drugs Market Research Report 2024

Anti-aging drugs are used to slow down or reverse the processes of aging to extend the lifespan. Aging, is that damage to the body’s macromolecules, cells, tissues, which is facilitated by genomic instability, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, oxidation damage by free radicals etc
According to Mr Accuracy reports’s new survey, global Anti-Ageing Drugs market is projected to reach US$ 140690 million in 2034, increasing from US$ 82060 million in 2024, with the CAGR of 7.5% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Anti-Ageing Drugs market research.
Key manufacturers engaged in the Anti-Ageing Drugs industry include Nu Skin, BIOTIME, Elysium Health, La Roche-Posay and DermaFix, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Anti-Ageing Drugs were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Anti-Ageing Drugs market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-Ageing Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Nu Skin
BIOTIME
Elysium Health
La Roche-Posay
DermaFix
Segment by Type
Hormonal Therapy
Antioxidants
Enzymes
Stem Cells
Others

Segment by Application


Skin
Hair
Others

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Anti-Ageing Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Anti-Ageing Drugs Market Overview
1.1 Product Overview and Scope of Anti-Ageing Drugs
1.2 Anti-Ageing Drugs Segment by Type
1.2.1 Global Anti-Ageing Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Hormonal Therapy
1.2.3 Antioxidants
1.2.4 Enzymes
1.2.5 Stem Cells
1.2.6 Others
1.3 Anti-Ageing Drugs Segment by Application
1.3.1 Global Anti-Ageing Drugs Market Value by Application: (2024-2034)
1.3.2 Skin
1.3.3 Hair
1.3.4 Others
1.4 Global Anti-Ageing Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-Ageing Drugs Revenue 2018-2034
1.4.2 Global Anti-Ageing Drugs Sales 2018-2034
1.4.3 Global Anti-Ageing Drugs Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Anti-Ageing Drugs Market Competition by Manufacturers
2.1 Global Anti-Ageing Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Anti-Ageing Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Anti-Ageing Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Anti-Ageing Drugs Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Anti-Ageing Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Ageing Drugs, Product Type & Application
2.7 Anti-Ageing Drugs Market Competitive Situation and Trends
2.7.1 Anti-Ageing Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Ageing Drugs Players Market Share by Revenue
2.7.3 Global Anti-Ageing Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Ageing Drugs Retrospective Market Scenario by Region
3.1 Global Anti-Ageing Drugs Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Anti-Ageing Drugs Global Anti-Ageing Drugs Sales by Region: 2018-2034
3.2.1 Global Anti-Ageing Drugs Sales by Region: 2018-2023
3.2.2 Global Anti-Ageing Drugs Sales by Region: 2024-2034
3.3 Global Anti-Ageing Drugs Global Anti-Ageing Drugs Revenue by Region: 2018-2034
3.3.1 Global Anti-Ageing Drugs Revenue by Region: 2018-2023
3.3.2 Global Anti-Ageing Drugs Revenue by Region: 2024-2034
3.4 North America Anti-Ageing Drugs Market Facts & Figures by Country
3.4.1 North America Anti-Ageing Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Anti-Ageing Drugs Sales by Country (2018-2034)
3.4.3 North America Anti-Ageing Drugs Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Ageing Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-Ageing Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Anti-Ageing Drugs Sales by Country (2018-2034)
3.5.3 Europe Anti-Ageing Drugs Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Ageing Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Ageing Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Anti-Ageing Drugs Sales by Country (2018-2034)
3.6.3 Asia Pacific Anti-Ageing Drugs Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Ageing Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-Ageing Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Anti-Ageing Drugs Sales by Country (2018-2034)
3.7.3 Latin America Anti-Ageing Drugs Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Ageing Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Ageing Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Anti-Ageing Drugs Sales by Country (2018-2034)
3.8.3 Middle East and Africa Anti-Ageing Drugs Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti-Ageing Drugs Sales by Type (2018-2034)
4.1.1 Global Anti-Ageing Drugs Sales by Type (2018-2023)
4.1.2 Global Anti-Ageing Drugs Sales by Type (2024-2034)
4.1.3 Global Anti-Ageing Drugs Sales Market Share by Type (2018-2034)
4.2 Global Anti-Ageing Drugs Revenue by Type (2018-2034)
4.2.1 Global Anti-Ageing Drugs Revenue by Type (2018-2023)
4.2.2 Global Anti-Ageing Drugs Revenue by Type (2024-2034)
4.2.3 Global Anti-Ageing Drugs Revenue Market Share by Type (2018-2034)
4.3 Global Anti-Ageing Drugs Price by Type (2018-2034)
5 Segment by Application
5.1 Global Anti-Ageing Drugs Sales by Application (2018-2034)
5.1.1 Global Anti-Ageing Drugs Sales by Application (2018-2023)
5.1.2 Global Anti-Ageing Drugs Sales by Application (2024-2034)
5.1.3 Global Anti-Ageing Drugs Sales Market Share by Application (2018-2034)
5.2 Global Anti-Ageing Drugs Revenue by Application (2018-2034)
5.2.1 Global Anti-Ageing Drugs Revenue by Application (2018-2023)
5.2.2 Global Anti-Ageing Drugs Revenue by Application (2024-2034)
5.2.3 Global Anti-Ageing Drugs Revenue Market Share by Application (2018-2034)
5.3 Global Anti-Ageing Drugs Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Nu Skin
6.1.1 Nu Skin Corporation Information
6.1.2 Nu Skin Description and Business Overview
6.1.3 Nu Skin Anti-Ageing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Nu Skin Anti-Ageing Drugs Product Portfolio
6.1.5 Nu Skin Recent Developments/Updates
6.2 BIOTIME
6.2.1 BIOTIME Corporation Information
6.2.2 BIOTIME Description and Business Overview
6.2.3 BIOTIME Anti-Ageing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BIOTIME Anti-Ageing Drugs Product Portfolio
6.2.5 BIOTIME Recent Developments/Updates
6.3 Elysium Health
6.3.1 Elysium Health Corporation Information
6.3.2 Elysium Health Description and Business Overview
6.3.3 Elysium Health Anti-Ageing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Elysium Health Anti-Ageing Drugs Product Portfolio
6.3.5 Elysium Health Recent Developments/Updates
6.4 La Roche-Posay
6.4.1 La Roche-Posay Corporation Information
6.4.2 La Roche-Posay Description and Business Overview
6.4.3 La Roche-Posay Anti-Ageing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 La Roche-Posay Anti-Ageing Drugs Product Portfolio
6.4.5 La Roche-Posay Recent Developments/Updates
6.5 DermaFix
6.5.1 DermaFix Corporation Information
6.5.2 DermaFix Description and Business Overview
6.5.3 DermaFix Anti-Ageing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 DermaFix Anti-Ageing Drugs Product Portfolio
6.5.5 DermaFix Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Ageing Drugs Industry Chain Analysis
7.2 Anti-Ageing Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Ageing Drugs Production Mode & Process
7.4 Anti-Ageing Drugs Sales and Marketing
7.4.1 Anti-Ageing Drugs Sales Channels
7.4.2 Anti-Ageing Drugs Distributors
7.5 Anti-Ageing Drugs Customers
8 Anti-Ageing Drugs Market Dynamics
8.1 Anti-Ageing Drugs Industry Trends
8.2 Anti-Ageing Drugs Market Drivers
8.3 Anti-Ageing Drugs Market Challenges
8.4 Anti-Ageing Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-Ageing Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Anti-Ageing Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Anti-Ageing Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-Ageing Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Anti-Ageing Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Anti-Ageing Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Anti-Ageing Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Anti-Ageing Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Anti-Ageing Drugs, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Anti-Ageing Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Ageing Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Ageing Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Ageing Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Ageing Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Ageing Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Anti-Ageing Drugs Sales by Region (2018-2023) & (K Units)
Table 18. Global Anti-Ageing Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Anti-Ageing Drugs Sales by Region (2024-2034) & (K Units)
Table 20. Global Anti-Ageing Drugs Sales Market Share by Region (2024-2034)
Table 21. Global Anti-Ageing Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Anti-Ageing Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Anti-Ageing Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Anti-Ageing Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America Anti-Ageing Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Anti-Ageing Drugs Sales by Country (2018-2023) & (K Units)
Table 27. North America Anti-Ageing Drugs Sales by Country (2024-2034) & (K Units)
Table 28. North America Anti-Ageing Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Anti-Ageing Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Anti-Ageing Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Anti-Ageing Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Europe Anti-Ageing Drugs Sales by Country (2024-2034) & (K Units)
Table 33. Europe Anti-Ageing Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Anti-Ageing Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Anti-Ageing Drugs Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Anti-Ageing Drugs Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Anti-Ageing Drugs Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Anti-Ageing Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Anti-Ageing Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Anti-Ageing Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Anti-Ageing Drugs Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Anti-Ageing Drugs Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Anti-Ageing Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Anti-Ageing Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Anti-Ageing Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Anti-Ageing Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Anti-Ageing Drugs Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Anti-Ageing Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Anti-Ageing Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Anti-Ageing Drugs Sales (K Units) by Type (2018-2023)
Table 51. Global Anti-Ageing Drugs Sales (K Units) by Type (2024-2034)
Table 52. Global Anti-Ageing Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Anti-Ageing Drugs Sales Market Share by Type (2024-2034)
Table 54. Global Anti-Ageing Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Anti-Ageing Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Anti-Ageing Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Anti-Ageing Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global Anti-Ageing Drugs Price (USD/Unit) by Type (2018-2023)
Table 59. Global Anti-Ageing Drugs Price (USD/Unit) by Type (2024-2034)
Table 60. Global Anti-Ageing Drugs Sales (K Units) by Application (2018-2023)
Table 61. Global Anti-Ageing Drugs Sales (K Units) by Application (2024-2034)
Table 62. Global Anti-Ageing Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Anti-Ageing Drugs Sales Market Share by Application (2024-2034)
Table 64. Global Anti-Ageing Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Anti-Ageing Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Anti-Ageing Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Anti-Ageing Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global Anti-Ageing Drugs Price (USD/Unit) by Application (2018-2023)
Table 69. Global Anti-Ageing Drugs Price (USD/Unit) by Application (2024-2034)
Table 70. Nu Skin Corporation Information
Table 71. Nu Skin Description and Business Overview
Table 72. Nu Skin Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Nu Skin Anti-Ageing Drugs Product
Table 74. Nu Skin Recent Developments/Updates
Table 75. BIOTIME Corporation Information
Table 76. BIOTIME Description and Business Overview
Table 77. BIOTIME Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. BIOTIME Anti-Ageing Drugs Product
Table 79. BIOTIME Recent Developments/Updates
Table 80. Elysium Health Corporation Information
Table 81. Elysium Health Description and Business Overview
Table 82. Elysium Health Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Elysium Health Anti-Ageing Drugs Product
Table 84. Elysium Health Recent Developments/Updates
Table 85. La Roche-Posay Corporation Information
Table 86. La Roche-Posay Description and Business Overview
Table 87. La Roche-Posay Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. La Roche-Posay Anti-Ageing Drugs Product
Table 89. La Roche-Posay Recent Developments/Updates
Table 90. DermaFix Corporation Information
Table 91. DermaFix Description and Business Overview
Table 92. DermaFix Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. DermaFix Anti-Ageing Drugs Product
Table 94. DermaFix Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Anti-Ageing Drugs Distributors List
Table 98. Anti-Ageing Drugs Customers List
Table 99. Anti-Ageing Drugs Market Trends
Table 100. Anti-Ageing Drugs Market Drivers
Table 101. Anti-Ageing Drugs Market Challenges
Table 102. Anti-Ageing Drugs Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Ageing Drugs
Figure 2. Global Anti-Ageing Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Anti-Ageing Drugs Market Share by Type in 2024 & 2034
Figure 4. Hormonal Therapy Product Picture
Figure 5. Antioxidants Product Picture
Figure 6. Enzymes Product Picture
Figure 7. Stem Cells Product Picture
Figure 8. Others Product Picture
Figure 9. Global Anti-Ageing Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Anti-Ageing Drugs Market Share by Application in 2024 & 2034
Figure 11. Skin
Figure 12. Hair
Figure 13. Others
Figure 14. Global Anti-Ageing Drugs Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Anti-Ageing Drugs Market Size (2018-2034) & (US$ Million)
Figure 16. Global Anti-Ageing Drugs Sales (2018-2034) & (K Units)
Figure 17. Global Anti-Ageing Drugs Average Price (USD/Unit) & (2018-2034)
Figure 18. Anti-Ageing Drugs Report Years Considered
Figure 19. Anti-Ageing Drugs Sales Share by Manufacturers in 2024
Figure 20. Global Anti-Ageing Drugs Revenue Share by Manufacturers in 2024
Figure 21. The Global 5 and 10 Largest Anti-Ageing Drugs Players: Market Share by Revenue in 2024
Figure 22. Anti-Ageing Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 23. Global Anti-Ageing Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 24. North America Anti-Ageing Drugs Sales Market Share by Country (2018-2034)
Figure 25. North America Anti-Ageing Drugs Revenue Market Share by Country (2018-2034)
Figure 26. U.S. Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Canada Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. Europe Anti-Ageing Drugs Sales Market Share by Country (2018-2034)
Figure 29. Europe Anti-Ageing Drugs Revenue Market Share by Country (2018-2034)
Figure 30. Germany Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. France Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. U.K. Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Italy Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Russia Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Asia Pacific Anti-Ageing Drugs Sales Market Share by Region (2018-2034)
Figure 36. Asia Pacific Anti-Ageing Drugs Revenue Market Share by Region (2018-2034)
Figure 37. China Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Japan Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. South Korea Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. India Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Australia Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Taiwan Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Indonesia Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Thailand Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Malaysia Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Philippines Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Latin America Anti-Ageing Drugs Sales Market Share by Country (2018-2034)
Figure 48. Latin America Anti-Ageing Drugs Revenue Market Share by Country (2018-2034)
Figure 49. Mexico Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Brazil Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Argentina Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Middle East & Africa Anti-Ageing Drugs Sales Market Share by Country (2018-2034)
Figure 53. Middle East & Africa Anti-Ageing Drugs Revenue Market Share by Country (2018-2034)
Figure 54. Turkey Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Saudi Arabia Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. U.A.E Anti-Ageing Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. Global Sales Market Share of Anti-Ageing Drugs by Type (2018-2034)
Figure 58. Global Revenue Market Share of Anti-Ageing Drugs by Type (2018-2034)
Figure 59. Global Anti-Ageing Drugs Price (USD/Unit) by Type (2018-2034)
Figure 60. Global Sales Market Share of Anti-Ageing Drugs by Application (2018-2034)
Figure 61. Global Revenue Market Share of Anti-Ageing Drugs by Application (2018-2034)
Figure 62. Global Anti-Ageing Drugs Price (USD/Unit) by Application (2018-2034)
Figure 63. Anti-Ageing Drugs Value Chain
Figure 64. Anti-Ageing Drugs Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed